Dozens of children put at risk after gender care failures at GP clinic, inquiry finds
Dozens of Children at Risk from Gender Care Failures at GP Clinic, Inquiry Finds
Dozens of children put at risk - Children’s health has come under scrutiny following an NHS inquiry that uncovered systemic issues in the care provided by a Brighton-based general practice, WellBN. The review revealed that 78 young patients, including those under 13, were prescribed puberty-blocking drugs and cross-sex hormones without thorough assessment, potentially exposing them to long-term risks. The clinic, which launched a transgender health service in 2020, faced criticism as families highlighted concerns over the treatment of minors. This case has sparked broader discussions about the safety and oversight of gender care in community clinics.
Systemic Oversight and Regulatory Actions
The investigation, initiated by NHS Sussex in June 2025, followed complaints from multiple families and a civil legal case targeting the clinic and the NHS. It found that 20 children were prescribed medications without face-to-face consultations between February 2023 and December 2025. In response, NHS England has suspended new prescriptions for minors and referred several staff members to regulatory bodies for further evaluation. The clinic is now under closer examination to ensure compliance with standards.
One unnamed physician has been suspended from NHS duties while the inquiry continues. Dr. Christopher Tibbs, the regional medical director, noted that clinicians at WellBN administered "specialist diagnosis, care, and treatment" without proper qualifications or authorization. He emphasized that this level of care should have been reserved for specialists, underscoring the seriousness of the lapses. The NHS has since urged the clinic to adopt stricter protocols to prevent similar issues.
Emotional and Psychological Impact on Families
"It's not just the medical damage, but the collateral damage for relationships and families that is far greater than people have ever really thought to examine," said Rachel Cashman, co-founder of PSHE Brighton. Her comments highlight the emotional toll on families affected by the clinic’s practices. A parent who pursued legal action described the situation as a "medical scandal," recounting how his 16-year-old son was given oestrogen without his knowledge. Another parent shared how the stress of the treatment led to a family member considering suicide, illustrating the profound consequences of inadequate care.
The clinic’s initiative, aimed at reducing wait times for gender care in England, initially attracted praise for its accessibility. However, the inquiry found that the service lacked sufficient safeguards, with staff sometimes making decisions without adequate oversight. This has raised questions about the balance between timely treatment and ensuring children’s safety. The BBC interviewed three anonymous parents whose children received care at WellBN, all of whom expressed concerns about the clinic’s approach.
Medication Prescriptions and Developmental Concerns
The report detailed how 44 children aged 16 and under were prescribed puberty-suppressing drugs, with 12 under the age of 13, including a 11-year-old. Additionally, 51 children in the same age group were given cross-sex hormones, such as masculinizing or feminizing agents, which can lead to irreversible physical changes. These medications were administered without sufficient medical evaluation, prompting worries about their long-term effects. The inquiry also highlighted that 53 of the 78 cases reviewed had potential neuro-developmental concerns, adding another layer of complexity to the issue.
WellBN acknowledged the "seriousness and sensitivity of the matters raised" in a statement, pledging to improve its care model. The clinic has since transferred most young patients to specialist NHS services, as confirmed by Dr. Charlotte Canniff, joint chief medical officer for Surrey and Sussex ICB. While this shift aims to address the immediate risks, it also underscores the need for better training and resources for community-based providers to handle gender care with precision.
Broader Implications for Health Education
Parents and educators argue that the focus on gender medication has overshadowed other aspects of children’s health. Rachel Cashman, part of a coalition advocating for health education reforms, stressed that conditions like autism or ADHD were not adequately addressed. The inquiry has sparked calls for a more holistic approach to care, ensuring that children’s diverse needs are considered. With 78 cases reviewed, the findings suggest a critical gap in the system that requires urgent attention to prevent future harm.